
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target
David R. Janero, Ganesh A. Thakur
Expert Opinion on Drug Discovery (2016) Vol. 11, Iss. 12, pp. 1223-1237
Open Access | Times Cited: 20
David R. Janero, Ganesh A. Thakur
Expert Opinion on Drug Discovery (2016) Vol. 11, Iss. 12, pp. 1223-1237
Open Access | Times Cited: 20
Showing 20 citing articles:
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 100
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 100
Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1188-1203
Closed Access | Times Cited: 97
Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1188-1203
Closed Access | Times Cited: 97
Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets
Srikrishnan Mallipeddi, David R. Janero, Nikolai Zvonok, et al.
Biochemical Pharmacology (2016) Vol. 128, pp. 1-11
Open Access | Times Cited: 81
Srikrishnan Mallipeddi, David R. Janero, Nikolai Zvonok, et al.
Biochemical Pharmacology (2016) Vol. 128, pp. 1-11
Open Access | Times Cited: 81
Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators
Sumanta Garai, Pushkar M. Kulkarni, Peter C. Schaffer, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 2, pp. 542-568
Open Access | Times Cited: 53
Sumanta Garai, Pushkar M. Kulkarni, Peter C. Schaffer, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 2, pp. 542-568
Open Access | Times Cited: 53
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation
Dinesh Thapa, Elizabeth A. Cairns, Anna-Maria Szczesniak, et al.
Molecules (2020) Vol. 25, Iss. 2, pp. 417-417
Open Access | Times Cited: 40
Dinesh Thapa, Elizabeth A. Cairns, Anna-Maria Szczesniak, et al.
Molecules (2020) Vol. 25, Iss. 2, pp. 417-417
Open Access | Times Cited: 40
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
Ken Soderstrom, Eman Soliman, Rukiyah Van Dross
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 40
Ken Soderstrom, Eman Soliman, Rukiyah Van Dross
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 40
Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy
Sumanta Garai, Luciana M. Leo, Anna-Maria Szczesniak, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8104-8126
Closed Access | Times Cited: 27
Sumanta Garai, Luciana M. Leo, Anna-Maria Szczesniak, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 8104-8126
Closed Access | Times Cited: 27
Identification of CB1 Receptor Allosteric Sites Using Force-Biased MMC Simulated Annealing and Validation by Structure–Activity Relationship Studies
Dow P. Hurst, Sumanta Garai, Pushkar M. Kulkarni, et al.
ACS Medicinal Chemistry Letters (2019) Vol. 10, Iss. 8, pp. 1216-1221
Open Access | Times Cited: 30
Dow P. Hurst, Sumanta Garai, Pushkar M. Kulkarni, et al.
ACS Medicinal Chemistry Letters (2019) Vol. 10, Iss. 8, pp. 1216-1221
Open Access | Times Cited: 30
Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities
Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Angelika Andrzejewska-Romanowska, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5874-5874
Open Access | Times Cited: 30
Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Angelika Andrzejewska-Romanowska, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 23, pp. 5874-5874
Open Access | Times Cited: 30
TheIn VivoEffects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
Elizabeth A. Cairns, Anna-Maria Szczesniak, Alex Straiker, et al.
Journal of Ocular Pharmacology and Therapeutics (2017) Vol. 33, Iss. 8, pp. 582-590
Open Access | Times Cited: 27
Elizabeth A. Cairns, Anna-Maria Szczesniak, Alex Straiker, et al.
Journal of Ocular Pharmacology and Therapeutics (2017) Vol. 33, Iss. 8, pp. 582-590
Open Access | Times Cited: 27
Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRABeCB2.0 Sensor
Samay Shivshankar, Josephine Nimely, Henry L. Puhl, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5012-5012
Open Access | Times Cited: 2
Samay Shivshankar, Josephine Nimely, Henry L. Puhl, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5012-5012
Open Access | Times Cited: 2
Design and Synthesis of Cannabinoid 1 Receptor (CB1R) Allosteric Modulators: Drug Discovery Applications
Abhijit Kulkarni, Sumanta Garai, David R. Janero, et al.
Methods in enzymology on CD-ROM/Methods in enzymology (2017), pp. 281-315
Closed Access | Times Cited: 13
Abhijit Kulkarni, Sumanta Garai, David R. Janero, et al.
Methods in enzymology on CD-ROM/Methods in enzymology (2017), pp. 281-315
Closed Access | Times Cited: 13
Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options
J. Daniel Lafreniere, Michael E. Kelly
Neuronal Signaling (2018) Vol. 2, Iss. 4
Open Access | Times Cited: 13
J. Daniel Lafreniere, Michael E. Kelly
Neuronal Signaling (2018) Vol. 2, Iss. 4
Open Access | Times Cited: 13
Microwave‐accelerated Conjugate Addition of 2‐Arylindoles to Substituted β‐Nitrostyrenes in the Presence of Ammonium Trifluoroacetate: An Efficient Approach for the Synthesis of a Novel Class of CB1 Cannabinoid Receptor Allosteric Modulators
Pushkar M. Kulkarni, Ameya Ranade, Sumanta Garai, et al.
Journal of Heterocyclic Chemistry (2017) Vol. 54, Iss. 3, pp. 2079-2084
Closed Access | Times Cited: 12
Pushkar M. Kulkarni, Ameya Ranade, Sumanta Garai, et al.
Journal of Heterocyclic Chemistry (2017) Vol. 54, Iss. 3, pp. 2079-2084
Closed Access | Times Cited: 12
Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure
Sumanta Garai, Peter C. Schaffer, Robert B. Laprairie, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 50, pp. 116421-116421
Closed Access | Times Cited: 9
Sumanta Garai, Peter C. Schaffer, Robert B. Laprairie, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 50, pp. 116421-116421
Closed Access | Times Cited: 9
Molecular insights into GPCR mechanisms for drugs of abuse
Omar B. Sánchez-Reyes, Gregory Zilberg, John D. McCorvy, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 9, pp. 105176-105176
Open Access | Times Cited: 3
Omar B. Sánchez-Reyes, Gregory Zilberg, John D. McCorvy, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 9, pp. 105176-105176
Open Access | Times Cited: 3
Assessing Allosteric Modulation of CB1 at the Receptor and Cellular Levels
Caitlin E. Scott, Debra A. Kendall
Methods in enzymology on CD-ROM/Methods in enzymology (2017), pp. 317-342
Open Access | Times Cited: 9
Caitlin E. Scott, Debra A. Kendall
Methods in enzymology on CD-ROM/Methods in enzymology (2017), pp. 317-342
Open Access | Times Cited: 9
Focused structure-activity relationship profiling around the 2-phenylindole scaffold of a cannabinoid type-1 receptor agonist-positive allosteric modulator: site-III aromatic-ring congeners with enhanced activity and solubility
Peter C. Schaffer, Pushkar M. Kulkarni, David R. Janero, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 21, pp. 115727-115727
Closed Access | Times Cited: 7
Peter C. Schaffer, Pushkar M. Kulkarni, David R. Janero, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 21, pp. 115727-115727
Closed Access | Times Cited: 7
Current strategic trends in drug discovery: the present as prologue
David R. Janero
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 2, pp. 147-159
Closed Access | Times Cited: 1
David R. Janero
Expert Opinion on Drug Discovery (2023) Vol. 19, Iss. 2, pp. 147-159
Closed Access | Times Cited: 1